SAVARINO, EDOARDO VINCENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 28.021
AS - Asia 14.528
EU - Europa 10.930
AF - Africa 5.213
SA - Sud America 4.262
OC - Oceania 482
Continente sconosciuto - Info sul continente non disponibili 208
Totale 63.644
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 25.484
SG - Singapore 4.479
BR - Brasile 2.553
HK - Hong Kong 2.318
IT - Italia 2.130
CN - Cina 1.784
VN - Vietnam 975
DE - Germania 902
FI - Finlandia 823
PL - Polonia 637
NL - Olanda 528
RU - Federazione Russa 500
FR - Francia 468
GB - Regno Unito 446
AT - Austria 304
AR - Argentina 299
SE - Svezia 297
MX - Messico 266
IN - India 261
TR - Turchia 246
KR - Corea 245
BJ - Benin 241
EC - Ecuador 235
ES - Italia 222
IE - Irlanda 201
ID - Indonesia 198
UA - Ucraina 187
EG - Egitto 184
ZA - Sudafrica 179
PE - Perù 176
AO - Angola 174
IQ - Iraq 173
CO - Colombia 171
JP - Giappone 171
AE - Emirati Arabi Uniti 170
RS - Serbia 168
PH - Filippine 165
PY - Paraguay 161
CL - Cile 160
AZ - Azerbaigian 153
CI - Costa d'Avorio 153
JO - Giordania 153
BE - Belgio 152
MA - Marocco 151
DK - Danimarca 150
LB - Libano 148
PK - Pakistan 148
PT - Portogallo 146
PA - Panama 145
SA - Arabia Saudita 144
CZ - Repubblica Ceca 143
KE - Kenya 143
UY - Uruguay 143
KG - Kirghizistan 140
LA - Repubblica Popolare Democratica del Laos 139
MR - Mauritania 139
NO - Norvegia 139
AL - Albania 138
DZ - Algeria 138
GR - Grecia 138
GT - Guatemala 138
RO - Romania 138
IR - Iran 137
MU - Mauritius 137
UZ - Uzbekistan 137
BB - Barbados 136
BF - Burkina Faso 136
VE - Venezuela 136
EE - Estonia 135
NI - Nicaragua 135
ME - Montenegro 134
ML - Mali 134
SN - Senegal 134
TH - Thailandia 134
CH - Svizzera 133
BA - Bosnia-Erzegovina 132
CY - Cipro 132
UG - Uganda 132
HN - Honduras 131
MY - Malesia 131
LV - Lettonia 130
IS - Islanda 129
KZ - Kazakistan 129
TN - Tunisia 129
CV - Capo Verde 128
ET - Etiopia 128
GH - Ghana 128
GF - Guiana Francese 127
LU - Lussemburgo 127
MW - Malawi 127
SK - Slovacchia (Repubblica Slovacca) 127
LY - Libia 126
MK - Macedonia 126
PS - Palestinian Territory 126
TJ - Tagikistan 126
BZ - Belize 125
GM - Gambi 125
JM - Giamaica 125
DO - Repubblica Dominicana 124
NP - Nepal 124
Totale 57.552
Salva come PNG Salva come JPEG
Città #
Fairfield 4.245
Singapore 2.670
Ashburn 2.499
Hong Kong 2.219
Woodbridge 2.097
Houston 1.977
Seattle 1.522
Cambridge 1.454
Wilmington 1.254
Ann Arbor 1.175
Chandler 1.134
Boardman 670
Beijing 607
Santa Clara 580
San Diego 557
Princeton 458
Bytom 443
Helsinki 397
Munich 380
Medford 372
Los Angeles 326
Des Moines 303
Ho Chi Minh City 300
Cotonou 231
Hefei 229
Chicago 217
Roxbury 217
Dong Ket 205
Padova 203
São Paulo 202
Milan 181
Vienna 168
Jacksonville 160
Nuremberg 152
Hanoi 151
Rome 147
Dublin 146
Amman 144
Abidjan 142
Baku 140
Luanda 140
New York 134
Dakar 132
Managua 132
Buffalo 130
Panama City 130
Nouakchott 129
Bridgetown 125
Kampala 124
Vientiane 124
Tashkent 123
Seoul 120
Bishkek 119
Castries 118
Libreville 118
Dushanbe 117
Montevideo 117
Bamako 115
London 115
Conakry 114
Nairobi 114
Accra 112
Praia 112
Riga 112
Ulan Bator 110
Phnom Penh 109
Harare 108
Lappeenranta 108
Redondo Beach 108
Nanjing 105
Lusaka 103
Podgorica 101
Ouagadougou 99
Antananarivo 98
Lima 98
Yerevan 98
Reykjavik 97
Cayenne 96
Kingstown 93
Havana 92
Kigali 92
Kinshasa 91
Lilongwe 91
Maputo 89
Andorra la Vella 88
Belgrade 87
Dar es Salaam 86
Addis Ababa 85
Tallinn 84
Minsk 83
Noumea 83
Warsaw 83
Istanbul 82
Djibouti 81
Niamey 81
Willemstad 81
Turku 80
Kingston 79
Tbilisi 78
Tripoli 78
Totale 36.905
Salva come PNG Salva come JPEG
Nome #
Updates to the modern diagnosis of GERD: Lyon consensus 2.0 590
The natural history of gastro-esophageal reflux disease: a comprehensive review 296
Effects of laparoscopic myotomy on the esophageal motility pattern of esophageal achalasia as measured by high-resolution manometry 275
Correlation between reflux burden, peristaltic function, and mucosal integrity in GERD patients 255
Esophagogastric junction morphology is associated with a positive impedance-pH monitoring in patients with GERD 237
A 10-day levofloxacin-based therapy in patients with resistant Helicobacter pylori infection: a controlled trial. 225
Step-up empiric elimination diet for pediatric and adult eosinophilic esophagitis: The 2-4-6 study 217
The Role of High-Resolution Manometry Before and Following Antireflux Surgery The Padova Consensus 209
Superior Mesenteric Artery Syndrome: a Prospective Study in a Single Institution 202
The natural history of achalasia: Evidence of a continuum-"The evolutive pattern theory" 196
A modification of Nissen fundoplication improves patients’ outcome and may reduce procedure-related failure rate 195
The GerdQ questionnaire and high resolution manometry support the hypothesis that proton pump inhibitor-responsive oesophageal eosinophilia is a GERD-related phenomenon 193
Noncoding RNAs as drivers of the phenotypic plasticity of oesophageal mucosa 190
Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis 188
Modern diagnosis of GERD: the Lyon Consensus 186
Achalasia and Obstructive Motor Disorders Are Not Uncommon in Patients With Eosinophilic Esophagitis 185
Modulation of inflammation in IBD: Alpha7nAChR expression and role of nicotine 183
Prevalence of Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis 183
The Impact of Heller Myotomy on Integrated Relaxation Pressure in Esophageal Achalasia 182
Helicobacter pylori infection does not protect against eosinophilic esophagitis: results from a large multicenter case-control study 181
A modified Nissen fundoplication: subjective and objective midterm results 180
Antimicrobial treatment with the fixed-dose antibiotic combination RHB-104 for Mycobacterium avium subspecies paratuberculosis in Crohn’s disease: pharmacological and clinical implications 178
Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis 178
The Chicago Classification of esophageal motility disorders, v3.0 176
Systematic review with meta-analysis: global prevalence of uninvestigated dyspepsia according to the Rome criteria 176
Microbiota changes induced by microencapsulated sodium butyrate in patients with inflammatory bowel disease 176
OLGA Gastritis Staging for the Prediction of Gastric Cancer Risk: A Long-term Follow-up Study of 7436 Patients 175
Comment on "Impairment of chemical clearance is relevant to the pathogenesis of refractory reflux oesophagitis" by Marzio Frazzoni et al. [Digestive and Liver Disease 2014;46:596-602] 173
Matrix Metalloproteinase 3 Predicts Therapeutic Response in Inflammatory Bowel Disease Patients Treated With Infliximab 173
Indications and interpretation of esophageal function testing 171
Clinical, endoscopic, histological and radiological characteristics of Italian patients with eosinophilic oesophagitis 170
Effects of omega-loop bypass on esophagogastric junction function 167
Faecal microbiota transplantation in Clostridioides difficile infection: real-life experience from an academic Italian hospital 167
Practice guidelines on the use of esophageal manometry - A GISMAD-SIGE-AIGO medical position statement 166
Esophageal biopsies in the management of GERD: Complementary tool for many but not for all 164
Fecal calprotectin in systemic sclerosis: Light and shade of a promising tool 164
Nonerosive reflux disease: Clinical concepts 164
A specific microbiota signature is associated to various degrees of ulcerative colitis as assessed by a machine learning approach 164
A safety review of proton pump inhibitors to treat acid-related digestive diseases 162
Ambulatory reflux monitoring for diagnosis of gastro-esophageal reflux disease: Update of the Porto consensus and recommendations from an international consensus group 161
Factors associated with disability in patients with ulcerative colitis: A cross-sectional study 161
REAL LIFE COMPARISON OF DIFFERENT ANTI-TNF BIOLOGIC THERAPIES FOR ULCERATIVE COLITIS TREATMENT: A RETROSPECTIVE COHORT STUDY 161
Normal values of esophageal motility after antireflux surgery; a study using high-resolution manometry 160
Analyses of the Post-reflux Swallow-induced Peristaltic Wave Index and Nocturnal Baseline Impedance Parameters Increase the Diagnostic Yield of Impedance-pH Monitoring of Patients With Reflux Disease 160
A comparison between sodium alginate and magaldrate anhydrous in the treatment of patients with gastroesophageal reflux symptoms. 160
Arterial congestive gastropathy: A new entity? 159
Anti-Tumor Necrosis Factor Antibodies for Prevention of Crohn's Disease Recurrence After Surgery: More Than a Hope 159
Duodenal Histological Findings and Risk of Coeliac Disease in Subjects with Autoimmune Atrophic Gastritis: A Retrospective Evaluation 159
NERD: an umbrella term including heterogeneous subpopulations. 158
Granulo-monocyto apheresis is more effective in mild ulcerative colitis than in moderate to severe disease. 158
A Comparison Between Lactose Breath Test and Quick Test on Duodenal Biopsies for Diagnosing Lactase Deficiency in Patients With Self-reported Lactose Intolerance. 157
The placebo effect is a relevant factor in evaluating effectiveness of therapies in functional gastrointestinal disorders 156
Quality of life after laparoscopic sigmoid resection for uncomplicated diverticular disease 154
Infliximab Originator, Infliximab Biosimilar, and Adalimumab Are More Effective in Crohn's Disease Than Ulcerative Colitis: A Real-Life Cohort Study 153
Factors Influencing Disability and Quality of Life during Treatment: A Cross-Sectional Study on IBD Patients 152
Fecal microbiota transplantation for norovirus infection: a clinical and microbiological success. 152
Nonerosive reflux disease and functional heartburn are clearly separate entities. 151
Low serum trough levels are associated with post-surgical recurrence in Crohn's disease patients undergoing prophylaxis with adalimumab 151
A propensity score-weighted comparison between adalimumab originator and its biosimilars, ABP501 and SB5, in inflammatory bowel disease: a multicenter Italian study 151
Expert consensus document: Advances in the physiological assessment and diagnosis of GERD 150
Classification of esophageal motor findings in gastro-esophageal reflux disease: Conclusions from an international consensus group 149
Weak Cytotoxic T Cells Activation Predicts Low-Grade Dysplasia Persistence in Ulcerative Colitis 148
The appropriate use of proton pump inhibitors (PPIs): Need for a reappraisal 147
Normal values of 24-h ambulatory intraluminal impedance combined with pH-metry in subjects eating a Mediterranean diet. 146
MicroRNAs as Predictive Biomarkers of Resistance to Targeted Therapies in Gastrointestinal Tumors 146
Characterization of Gut Microbiome Composition in Patients with Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy 145
Adalimumab trough levels and response to biological treatment in patients with inflammatory bowel disease: A useful cutoff in clinical practice 145
A more in-depth evaluation of impedance-pH could assist in distinguishing reflux-related from reflux-unrelated heartburn 145
Characteristics of reflux episodes and symptom association in patients with erosive esophagitis and nonerosive reflux disease: study using combined impedance-pH off therapy. 145
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study 145
Influence of Diet on the Course of Inflammatory Bowel Disease 144
The 2018 ISDE Achalasia guidelines 144
Adalimumab biosimilars, ABP501 and SB5, are equally effective and safe as adalimumab originator 144
Measurement of oro-caecal transit time by magnetic resonance imaging. 143
A survey on nutritional knowledge in coeliac disease compared to inflammatory bowel diseases patients and healthy subjects 143
Topical Protection of Esophageal Mucosa as a New Treatment of GERD 143
Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility 142
Achalasia with dense eosinophilic infiltrate responds to steroid therapy. 142
Innovative techniques in evaluating the esophagus; imaging of esophageal morphology and function; and drugs for esophageal disease. 142
Symptom association analysis is important in GERD patients undergoing endoscopic therapy 142
Safety of potassium-competitive acid blockers in the treatment of gastroesophageal reflux disease 141
Letter: proton pump inhibitor-responsive oesophageal eosinophilia – more than just gastro-oesophageal reflux disease. Authors' reply 141
Gastrointestinal: An unusual rectal finding in a patient with ulcerative colitis 141
Case report faecal microbiome transplantation as a solution to chronic enteropathies in dogs: A case study of beneficial microbial evolution 141
Gastric metastases of breast cancer: Histopathological and molecular characterization of a single Institution case series 141
Between GERD and NERD: the relevance of weakly acidic reflux 140
Esophageal mucosal innervation in functional heartburn: Closer to healthy asymptomatic subjects than to non-erosive reflux disease patients 140
Combined multichannel intraluminal impedance and manometry testing. 140
The reason for failure of on-demand PPI therapy in NERD patients. 139
Lactulose breath test to assess oro-cecal transit delay and estimate esophageal dysmotility in scleroderma patients. 139
Updates in the field of non-esophageal gastroesophageal reflux disorder 138
Biliary Tree Diagnostics: Advances in Endoscopic Imaging andand Tissue Sampling 137
Non-erosive reflux disease patients are more complex than the sole endoscopy tells us. 137
Optimal number of multiple rapid swallows needed during high-resolution esophageal manometry for accurate prediction of contraction reserve 137
Gastric fundal splenosis presenting as a stromal tumor and diagnosed by endoscopic ultrasound-guided SharkCore biopsy 137
In-vivo Axial-strain Sonoelastography Helps Distinguish Acutely-inflamed from Fibrotic Terminal Ileum Strictures in Patients with Crohn's Disease: Preliminary Results 136
A review of pharmacotherapy for treating gastroesophageal reflux disease (GERD) 136
Epstein-Barr virus associated gastric dysplasia: a new rare entity? 136
Noninfectious interstitial lung disease during infliximab therapy: case report and literature review. 136
Association Between Baseline Impedance Values and Response Proton Pump Inhibitorsin Patients With Heartburn. 135
Totale 16.753
Salva come PNG Salva come JPEG
Categoria #
all - tutte 213.809
article - articoli 213.504
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 427.313
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.061 0 0 0 0 187 302 385 364 567 479 294 483
2021/20226.157 284 611 666 364 607 304 403 589 544 170 478 1.137
2022/20233.013 732 132 91 352 424 407 28 189 335 57 201 65
2023/20242.499 125 245 207 177 173 211 209 167 141 100 374 370
2024/202512.675 53 714 556 330 1.301 338 642 1.065 1.492 687 2.137 3.360
2025/202626.960 2.146 4.582 9.371 10.113 748 0 0 0 0 0 0 0
Totale 64.358